As increasingly potent and complex small molecules enter development pipelines, manufacturers face mounting challenges in formulating these compounds into effective oral medications. At the core of these challenges lies particle size control — a critical factor that directly impacts solubility, bioavailability, safety and regulatory compliance.
read more